Current Appointments & Affiliations
Wellcome Clinical Distinguished Professor of Medicine
·
2022 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor of Medicine
·
2017 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2007 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Clinical Validation of Duoseq, a Novel Assay for Clinical DNA and RNA Sequencing.
Journal Article J Mol Diagn · January 2026 Next-generation sequencing (NGS) has become integral to the clinical workup of blood cancers. However, there remain barriers to implementing clinical NGS, including the separate workflows required for DNA and RNA sequencing, complex bioinformatics analyses ... Full text Link to item CiteReal-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.
Journal Article Blood · October 30, 2025 Epcoritamab and glofitamab are CD20-directed bispecific antibodies (BsAbs) approved in the United States for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). Limited data exist for patients treated outside of trials. Patients with R/R DL ... Full text Link to item CiteIntegrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
Journal Article Am J Hematol · September 2025 Nodal follicular helper T-cell (T FH) lymphoma of the angioimmunoblastic (AITL) subtype has a dismal prognosis. Using whole-exome sequencing (n = 124), transcriptomic (n = 78), and methylation (n = 40) analysis, we identified recurrent mutations in known e ... Full text Link to item CiteRecent Grants
R01: Genetic Origins of Adverse Outcomes in African Americans with Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028Clinical and Genetic of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2027Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027View All Grants
Education, Training & Certifications
Northwestern University ·
1999
M.D.